Cargando…

Role of Bupropion and Naltrexone in Managing Depression With Polycystic Ovary Syndrome: A Case Report and Literature Review

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age. Women with PCOS may present with obesity, amenorrhea, oligomenorrhea, infertility, or androgenic features. Studies have shown the association of psychiatric disorders with endocrine disorders, inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Kaushal, Kulkarni, Ritu, Singh, Romil, Pannu, Harmandeep S, Kamrai, Dhwani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719465/ https://www.ncbi.nlm.nih.gov/pubmed/33304679 http://dx.doi.org/10.7759/cureus.11343

Ejemplares similares

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

How Essential Is to Focus on Physician's Health and Burnout in Coronavirus (COVID-19) Pandemic?
por: Shah, Kaushal, et al.
Publicado: (2020)

Impact of COVID-19 on the Mental Health of Children and Adolescents
por: Shah, Kaushal, et al.
Publicado: (2020)

Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
por: Xing, Liwei, et al.
Publicado: (2022)

School-Based Approaches to Prevent Depression in Adolescents
por: Bodicherla, Krishna Priya, et al.
Publicado: (2021)

Effect of combined naltrexone and bupropion therapy on the brain’s functional connectivity
por: Wang, Gene-Jack, et al.
Publicado: (2018)

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014)

The Burden of Rotavirus Gastroenteritis in Children: A Hospital-Based Prospective Study in Western Rajasthan
por: Meel, Suresh Kumar, et al.
Publicado: (2020)

Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues
por: Wang, G-J, et al.
Publicado: (2014)

Use of Bupropion in the Management of Negative Symptom Schizophrenia: A Case Series
por: Perera, Pradilka, et al.
Publicado: (2022)

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
por: Tek, Cenk
Publicado: (2016)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

Does Bupropion Impact More than Mood? A Case Report and Review of the Literature
por: Yasin, Waqas, et al.
Publicado: (2019)

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
por: Lyu, Xuechan, et al.
Publicado: (2018)

Metastatic Pancreatic-Biliary Cancer Presenting as Intramuscular Fluid Collections: A Case Report
por: Singh, Romil, et al.
Publicado: (2020)

Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
por: McElroy, Susan L., et al.
Publicado: (2013)

The Prevalence and Factors Associated With Anxiety-Like and Depression-Like Behaviors in Women With Polycystic Ovary Syndrome
por: Lin, Han, et al.
Publicado: (2021)

Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Buehler, Anna M
Publicado: (2015)

Symptoms of exhibitionism that regress with bupropion: A case report
por: Vayısoğlu, Sefa
Publicado: (2023)

The Role of Psychological First Aid to Support Public Mental Health in the COVID-19 Pandemic
por: Shah, Kaushal, et al.
Publicado: (2020)

Psychotic Symptoms in Heroin Withdrawal: A Case Report
por: Sharma, Surabhi, et al.
Publicado: (2021)

Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats
por: Scudeler, Monica Alhadas, et al.
Publicado: (2022)

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy
por: le Roux, Carel W., et al.
Publicado: (2022)

Development and validation of a prediction model for depression in adolescents with polycystic ovary syndrome: A study protocol
por: Ding, Rui, et al.
Publicado: (2022)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021)

A Systematic Review of Abuse or Overprescription of Bupropion in American Prisons and a Synthesis of Case Reports on Bupropion Abuse in American Prison and Non-prison Systems
por: Aikoye, Salisu, et al.
Publicado: (2023)

Naltrexone/Bupropion extended release‐induced weight loss is independent of nausea in subjects without diabetes
por: Hong, K., et al.
Publicado: (2016)

Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
por: Siamidi, Angeliki, et al.
Publicado: (2021)

Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion
por: Halseth, A., et al.
Publicado: (2018)

Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity
por: Halseth, Amy, et al.
Publicado: (2016)

Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesity
por: Welling, Mila S., et al.
Publicado: (2023)

Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder
por: Kohno, Milky, et al.
Publicado: (2019)

Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings from the Past Outbreaks
por: Shah, Kaushal, et al.
Publicado: (2020)

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study
por: Guerdjikova, Anna I., et al.
Publicado: (2017)

Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine
por: Abdel-Gawad, Sherif A., et al.
Publicado: (2018)

Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis
por: Pi-Sunyer, Xavier, et al.
Publicado: (2019)

A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers
por: Walsh, Annabel E. L., et al.
Publicado: (2018)

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter
por: Milenkovic, Ivan, et al.
Publicado: (2021)

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study
por: Ray, Lara A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n5204rg3em1bcg7eom3m4j2eao